Yi‐Ling Qiu

600 total citations
30 papers, 388 citations indexed

About

Yi‐Ling Qiu is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Yi‐Ling Qiu has authored 30 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 12 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Yi‐Ling Qiu's work include Pediatric Hepatobiliary Diseases and Treatments (17 papers), Drug Transport and Resistance Mechanisms (11 papers) and Liver Disease Diagnosis and Treatment (5 papers). Yi‐Ling Qiu is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (17 papers), Drug Transport and Resistance Mechanisms (11 papers) and Liver Disease Diagnosis and Treatment (5 papers). Yi‐Ling Qiu collaborates with scholars based in China, Austria and Canada. Yi‐Ling Qiu's co-authors include Jian‐She Wang, Yi Lu, Jing‐Yu Gong, Meihong Zhang, A. S. Knisely, Jiaqi Li, Yanyan Yan, Liting Li, Qinghe Xing and Xin‐Bao Xie and has published in prestigious journals such as PLoS ONE, Hepatology and Biochemical and Biophysical Research Communications.

In The Last Decade

Yi‐Ling Qiu

28 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Ling Qiu China 12 247 161 98 92 61 30 388
Melissa Sambrotta United Kingdom 6 179 0.7× 153 1.0× 104 1.1× 32 0.3× 74 1.2× 7 276
Pieter‐Jan Cuyle Belgium 10 106 0.4× 146 0.9× 102 1.0× 93 1.0× 16 0.3× 22 345
Philip Stein United States 10 128 0.5× 87 0.5× 132 1.3× 29 0.3× 50 0.8× 12 411
N. Roy-Chowdhury United States 6 158 0.6× 31 0.2× 41 0.4× 64 0.7× 153 2.5× 10 344
Chunfang Gao China 11 315 1.3× 196 1.2× 84 0.9× 22 0.2× 41 0.7× 19 469
Pamela Leckie United Kingdom 7 131 0.5× 95 0.6× 109 1.1× 18 0.2× 213 3.5× 13 354
Xianjun Lao China 15 55 0.2× 94 0.6× 74 0.8× 46 0.5× 38 0.6× 29 406
Katsushi Amano Japan 9 110 0.4× 77 0.5× 252 2.6× 29 0.3× 286 4.7× 12 423
Aleta R. Crawford United States 8 260 1.1× 293 1.8× 208 2.1× 12 0.1× 169 2.8× 8 525

Countries citing papers authored by Yi‐Ling Qiu

Since Specialization
Citations

This map shows the geographic impact of Yi‐Ling Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Ling Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Ling Qiu more than expected).

Fields of papers citing papers by Yi‐Ling Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Ling Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Ling Qiu. The network helps show where Yi‐Ling Qiu may publish in the future.

Co-authorship network of co-authors of Yi‐Ling Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Ling Qiu. A scholar is included among the top collaborators of Yi‐Ling Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Ling Qiu. Yi‐Ling Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
She, Haicheng, Yi‐Ling Qiu, Ye Cheng, et al.. (2025). A liver-specific mouse model for MYO5B-associated cholestasis reveals a toxic gain-of-function as underlying disease mechanism. Biochemical and Biophysical Research Communications. 758. 151669–151669. 1 indexed citations
2.
Wang, Renxue, Chenzhi Hao, Yi‐Ling Qiu, et al.. (2024). ZFYVE19 deficiency: a ciliopathy involving failure of cell division, with cell death. Journal of Medical Genetics. 61(8). 750–758. 2 indexed citations
3.
Ding, Jian, Yi‐Ling Qiu, Renxue Wang, et al.. (2024). Loss of hepatocyte Usp53 protects mice from a form of xenobiotic-induced liver injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167624–167624. 2 indexed citations
4.
5.
6.
Zhao, Jing, Yi‐Ling Qiu, Xin‐Bao Xie, et al.. (2023). Recurrent AKR1D1 c.580-13T>A Variant. Journal of Molecular Diagnostics. 25(4). 227–233. 2 indexed citations
7.
Abuduxikuer, Kuerbanjiang, Chenzhi Hao, Jing Zhang, et al.. (2022). Defining pathogenicity of NOTCH2 variants for diagnosis of Alagille syndrome type 2 using a large cohort of patients. Liver International. 42(8). 1836–1848. 4 indexed citations
8.
Qiu, Yi‐Ling, Min Huang, Min Lian, et al.. (2022). Association of novel TMEM67 variants with mild phenotypes of high gamma‐glutamyl transpeptidase cholestasis and congenital hepatic fibrosis. Journal of Cellular Physiology. 237(6). 2713–2723. 1 indexed citations
9.
Qiu, Yi‐Ling, Hongmei Xu, Jing Zhu, et al.. (2021). MYO5B‐associated diseases: Novel liver‐related variants and genotype‐phenotype correlation. Liver International. 42(2). 402–411. 11 indexed citations
10.
Yang, Ye, Jing Zhang, Liting Li, et al.. (2021). Whole-Genome Sequencing Reveals Large ATP8B1 Deletion/Duplications as Second Mutations Missed by Exome-Based Sequencing. Journal of Molecular Diagnostics. 23(11). 1491–1499. 2 indexed citations
11.
Fang, Weiyuan, Kuerbanjiang Abuduxikuer, Peng Shi, et al.. (2021). Pediatric Wilson disease presenting as acute liver failure: Prognostic indices. World Journal of Clinical Cases. 9(14). 3273–3286. 8 indexed citations
12.
IJzendoorn, Sven C.D. van, et al.. (2020). Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low‐Gamma‐Glutamyltransferase Cholestasis. Hepatology. 72(4). 1461–1468. 19 indexed citations
13.
Abuduxikuer, Kuerbanjiang, Jing Zhang, Yi‐Ling Qiu, et al.. (2020). NBAS disease: 14 new patients, a recurrent mutation, and genotype–phenotype correlation among 24 Chinese patients. Hepatology Research. 50(11). 1306–1315. 9 indexed citations
14.
Wang, Renxue, Jun Han, Yi‐Ling Qiu, et al.. (2020). Changes in plasma bile acid profiles after partial internal biliary diversion in PFIC2 patients. Annals of Translational Medicine. 8(5). 185–185. 7 indexed citations
15.
Zhang, Jing, Jing‐Yu Gong, Chenzhi Hao, et al.. (2019). TJP2 hepatobiliary disorders: Novel variants and clinical diversity. Human Mutation. 41(2). 502–511. 24 indexed citations
16.
Wang, Yangong, et al.. (2018). A novel mutation in EYA1 in a Chinese family with Branchio-oto-renal syndrome. BMC Medical Genetics. 19(1). 139–139. 26 indexed citations
17.
Li, Jiaqi, Yi‐Ling Qiu, Jing‐Yu Gong, et al.. (2017). Novel NBAS mutations and fever-related recurrent acute liver failure in Chinese children: a retrospective study. BMC Gastroenterology. 17(1). 77–77. 22 indexed citations
18.
Qiu, Yi‐Ling, Jing‐Yu Gong, Jun Han, et al.. (2016). Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ‐glutamyltransferase cholestasis. Hepatology. 65(5). 1655–1669. 91 indexed citations
19.
Lu, Yulan, Ping Zhang, Meihong Zhang, et al.. (2016). A Specially Designed Multi-Gene Panel Facilitates Genetic Diagnosis in Children with Intrahepatic Cholestasis: Simultaneous Test of Known Large Insertions/Deletions. PLoS ONE. 11(10). e0164058–e0164058. 36 indexed citations
20.
Li, Liting, Jibin Dong, Hongmei Guo, et al.. (2015). JAG1 Mutation Spectrum and Origin in Chinese Children with Clinical Features of Alagille Syndrome. PLoS ONE. 10(6). e0130355–e0130355. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa Sambrotta Breakdown of academic impact, for papers by Pieter‐Jan Cuyle Breakdown of academic impact, for papers by Philip Stein Breakdown of academic impact, for papers by N. Roy-Chowdhury Breakdown of academic impact, for papers by Chunfang Gao Breakdown of academic impact, for papers by Pamela Leckie Breakdown of academic impact, for papers by Xianjun Lao Breakdown of academic impact, for papers by Katsushi Amano Breakdown of academic impact, for papers by Aleta R. Crawford
Rankless by CCL
2026